Dr. Jon Pierce-Shimomura, Associate Professor in the Department of Neuroscience at the University of Texas Austin talks about their unique program that pairs neuroscience graduate students with those that suffer from neurological diseases to better understand the whole patient and provide opportunities for everyone to learn about treating the ill and disabled.

#neuroscience

@SfNTweets

#SfN16

University of Texas Austin Graduate School of Neuroscience

Renee Cockerham PhD is the Neuroscience Program Manager at the University of Maryland School of Medicine. I talked with Renee at the annual meeting of the Society of Neuroscience about how enthusiasm for science is hard to teach but other skills can be learned. She also emphasizes that diverse backgrounds are needed in the growing field of neuroscience as they prepare the next generation of scientists.

#neuroscience

@SfNTweets

#SfN16

Lifesciences.umaryland.edu/neuroscience

Greg Gage, CEO and Co-Founder, Backyard Brains talks about bringing affordable neuroscience tools to kids and classrooms to stimulate thinking about how our brain communicates with our senses. I met Greg at the recent annual meeting of the Society for Neuroscience where his fun experiments were a stark contrast to the high tech expensive equipment on the show floor being sold for clinical research.

@BackyardBrains

#Neuroscience

@SfNtweets

#SfN16

Backyard Brains

Kim Walpole, co-founder and CEO, Trials.ai an EvoNexus portfolio company that is replacing paper based clinical trial systems with digital access to the hundreds of data points from participants, leveraging artificial intelligence to allow for more efficient trials, and providing transparency for patients and researchers.

@evonexus

Trials.ai

Robin Smith, CEO, Orig3n, a genomics company that is bringing personalized genetic analysis to consumers to inform about lifestyle choices and risks. With a broader mission to get a snapshot of humanity to support regenerative medicine efforts and find clues to rare diseases, they are collecting genetic material from cheek swabs and blood samples from a wide range of groups. My sample was collected at the recent Exponential Medicine conference and opened a door into a whole new kind of conversation about health and wellness.

@Orig3n_Inc

@ExponentialMed

#XMed

Orig3n.com

Arnon Zamir, Chief Change Maker, Tikkun Olam Makers talks about creating virtual and physical communities to address the neglected problems of the disabled. With a mission to use available technology and to openly share the results, volunteers come together with those with disabilities in Makeathons to come up with creative solutions. Arnon is most excited about 3-D printing which can empower people in remote places to replicate designs and add their own innovations.

#XMED

@ExponentialMed

TOMGlobal.org

Dexter Ang, CEO, Pison Technology, an MIT start-up is developing breakthrough technology using electromyography or EMG to detect nerve signals with sensors that allow command of compatible devices. Dexter began his quest to address the needs of ALS patients by placing sensors on their bodies that use wi-fi to control a computer, phone or wheelchair by having the patient think about the muscle movement. The possibilities for all humans are endless.

@pisontechnology

#XMED

@exponentialMed

Pison Technology

Nadeem Sarwar PhD, President, Eisai AiM Institute talks about the dramatic changes taking place in the development of targeted theraputics because of the introduction of human genomic data rather than just relying on animal testing, building more sophisticated drug discovery models, and how the timing of intervention is shifting to earlier in the disease cycle.

@EisaiUS

Eisai

Edwin Chau Senior Sales Manager Affymetrix eBioscience was exhibiting at the Festival of Genomics California and took the time to talk about their ground-breaking microarray solutions and other tools that are helping researchers increase their efficiency and get a better picture of disease.

@ebioscience

#FestivalofGenomics

ebioscience.affymetrix.com

David Winternheimer, PhD Business Development, DxTerity talks to me from the show floor of the recent Festival of Genomics California where he demonstrates how easy it is for patients to get a blood sample to participate in research initiatives that are using rich diagnostic data from their genomic testing to investigate a wide range of diseases.

#FestivalofGenomics

DxTerity.com